Fund Name | Location |
51 Blue Stone Ln | - |
Chengdu Yingchuang Taifu Guquan Touzi Jijin Guanli Youxian Gongsi | Chengdu, China, Sichuan |
European Life Sciences Growth Fund | - |
Global Growth Capital | England, London, United Kingdom |
Halcyon Incubator | District of Columbia, United States, Washington |
JW Levin Management Partners | - |
Kikuchi Seisakusho | Hachioji, Japan |
Kshatriya ventures | India, Maharashtra, Mumbai |
Lanzhe Capital | - |
Privet Capital | England, London, United Kingdom |
SG INCUBATE | Fukuoka, Fukuoka Prefecture, Japan |
Tianji Yilian Keji | Beijing, Beijing, China |
Tokyo Kiraboshi Financial Group | Japan, Tokyo |
Trailblazer Capital | Dallas, Texas, United States |
TrenLab | Community of Madrid, Madrid, Spain |
Vision Plus Capital | China, Hangzhou, Zhejiang |
Xplorer Capital | California, Menlo Park, United States |
Zhuhai Hengqin Shijing Touzi Hehuoqiye (Limited Partnership) | China, Guangdong, Zhuhai |
Zhuifeng Touzi | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
HDAX Therapeutics | $3M | 05 Sep 2024 | Toronto, Ontario, Canada | ||
Tenomix | $1M | 01 Mar 2024 | London, Ontario, Canada | ||
AmacaThera | 01 Jan 2016 | Old Toronto, Ontario, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
HDAX Therapeutics | $3M | 05 Sep 2024 | Toronto, Ontario, Canada | ||
Tenomix | $1M | 01 Mar 2024 | London, Ontario, Canada | ||
AmacaThera | 01 Jan 2016 | Old Toronto, Ontario, Canada |